Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 69 for “"synucleinopathy"”.
-
STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy
… and neurodegeneration arising from α-synucleinopathy in PD.
-
Sex-specific effects of developmental dieldrin exposure on synucleinopathy
… increases susceptibility to α-syn PFF-induced synucleinopathy. Dams were fed either dieldrin (0.3 mg/kg, every 3-4 days) or vehicle corn oil starting 1 month prior to breeding and continuing through weaning of pups at postnatal day 22. At 12 weeks of age, male and female offspring received …
-
Defining the role of acyl-CoA synthetase 6 on α-synucleinopathy
… known to elicit neuroprotection in models of synucleinopathy. To address this controversy, we have leveraged our lab's recent discovery that long-chain acyl-CoA synthetase 6 (ACSL6) is responsible for the neuronal membrane enrichment of DHA. We have shown that loss of ACSL6, and consequent …
-
Defining the role of acyl-CoA synthetase 6 on α-synucleinopathy
… known to elicit neuroprotection in models of synucleinopathy. To address this controversy, we have leveraged our lab’s recent discovery that long-chain acyl-CoA synthetase 6 (ACSL6) is responsible for the neuronal membrane enrichment of DHA. We have shown that loss of ACSL6, and consequent …
-
Soluble lymphocyte activation gene-3 contributes to α-synucleinopathy and related therapeutic development
… however, the role of sLag3 in mediating α-synucleinopathy is completely unknown. Here, we used sLag3 lacking mice (membrane-bound Lag3 still exists) can reduce α-Syn pathology spreading from the gut to the brain, following by the discovery of facilitation of α-Syn PFF uptake in primary …
-
The Dopaminergic Cell-Intrinsic Clock And Bidirectional Relationships Of Circadian Disruption And Synucleinopathy
… loss in both SNc and VTA-originating DANs in synucleinopathy. Taken together, these experiments further our understanding of the clock regulation of DANs, which may reveal therapeutic targets to abate neurodegeneration in PD.
-
Development of novel gene therapy approaches to target synucleinopathy in vitro and in vivo
… prevention of α-synaggregation and subsequent synucleinopathy illustrates an interesting avenue fordevelopment of novel PD therapies.Gene therapy involves modifying genetic material to treat or cure a disease andcould be used to protect the brain from neurotoxic α-syn aggregation. In study I, …
-
Murder On The Axonal Express: Synucleinopathy Disruption Of 14-3-3 Protein-Protein Interactions Impairs Axonal Trafficking
… have been shown to be protective in multiple synucleinopathy models. However, reduced soluble levels of 14-3-3s and increased phosphorylation of 14-3-3θ at S232 observed in synucleinopathies like DLB may impair their protec-tive ability, potentially due to disruptions in their PPIs. In this …
-
Deep brain stimulation of the subthalamic nucleus increases brain-derived neurotrophic factor in the context of synucleinopathy
… levels have yet to be examined in the context of synucleinopathy.In this dissertation I examine the effects of STN DBS on BDNF in the preformed fibril synucleinopathy model. PFF injection resulted in accumulation of phosphorylated α-syn (pSyn) inclusions in the substantia nigra pars compacta …
-
The temporal relationship between synucleinopathy, nigrostriatal degeneration, and neuroinflammation in the alpha-synuclein preformed fibril model of Parkinson's disease
… of neuroinflammation at different stages of synucleinopathy without the confound of α-syn pathology and degeneration occurring concurrently. First, I histologically examined the time course of synucleinopathy, microgliosis and nigral degeneration at monthly intervals. Microglia in the …
-
Influence of Chronic Adenosine A1 Receptor Stimulation on α-Synucleinopathy and Neurodegeneration Studied with In Vitro, In Silico, and In Vivo Approaches
… neurons and glial cells are the staples of many synucleinopathy disorders, such as Parkinson’s disease. Since brain adenosine becomes greatly elevated in aging brains and chronic adenosine A1 receptor (A1R) stimulation leads to neurodegeneration, we determined whether adenosine or A1R receptor …
-
The Influence of Age, Gender, and Thiol Repletion in an In Vivo Model of Lewy Body Disorders
… for generating reproducible and robust α-synucleinopathy in the limbic temporal lobe following infusions of preformed α-synuclein iv fibrils into the mouse olfactory bulb, which is frequently the first brain region to display Lewy pathology in humans. Our tract-tracer studies revealed that …
-
Pre-clinical screening for re-purposed and novel compounds that reduce synucleinopathy, and investigation of LRRK2 activity and VPS35 function within human cell culture models of Parkinson’s disease
… reduce ⍺Synuclein pathology. To model Lewy-like synucleinopathy we seeded mDA neurons with ⍺Synuclein pre-formed fibrils (PFFs) and quantified the amount of phospho-Serine-129 (pS129) ⍺Synuclein formed in neurons. This screen involved compounds that are reported to target ⍺Synuclein directly …
-
The Effects Of 27-Hydroxycholesterol And Palmitic Acid On Parkinson's Disease-Like Pathology
… including 27-OHC, within the brains of synucleinopathy patients. However, the extent to which increased 27-OHC levels in the brain causes α-syn deposition and promotes synucleinopathies is yet to be determined. Therefore, in this dissertation we explore the effects of 27-OHC on the …
-
Sex-specific Effects of Chaperone and Glial Defenses on Experimental Lewy Body Disease
… we tested if the sex-skewedness in the ensuing α-synucleinopathy was mediated by sex differences in intrinsic defenses that regulate protein homeostasis, such as the Hsp70 disaggregation machinery. Using primary rodent cultures as well as postmortem age- and sex-matched human tissue from subjects …
-
THE EFFECTS OF DEVELOPMENTAL EXPOSURE TO THE ORGANOCHLORINE PESTICIDE DIELDRIN ON SUSCEPTIBILITY TO PARKINSON’S DISEASE
… development show increased susceptibility to synucleinopathy induced by α- synuclein (α-syn) preformed fibrils (PFFs), with dieldrin-induced exacerbation of PFF-induced deficits in motor behavior and dopamine (DA) turnover. We hypothesize that dieldrin-induced epigenetic modification during …
-
THE EFFECT OF NOVEL MICROTUBULE MODULATORS ON EXPERIMENTAL LEWY BODY DISEASE
… both compounds reduced preformed fibril-seeded α-synucleinopathy without toxicity in primary hippocampal cultures. AG161-47 subtly impacted microtubule stability markers in primary hippocampal cultures, and its mitigating effects on α-synucleinopathy and nuclear fragmentation were interrupted by …
-
The Multipurpose DNA Repair/Redox Protein APE1 in Rodent and Human Lewy Body Disease
… in vivo. In Aim 2, we measured the effects of α-synucleinopathy and biological sex on APE1 expression and DNA excision/repair function in mice and humans. Given findings of dense α-synucleinopathy in the anterior olfactory nucleus and amygdala of humans with Lewy body disease that may contribute …
-
Clinical and neuroimaging markers of prodromal neurodegeneration in rapid eye movement sleep behaviour disorder
… of developing Parkinson’s disease or a related synucleinopathy. Their individual trajectories are enormously varied, however, causing considerable prognostic uncertainty. This thesis examined aspects of the clinical and neuroimaging phenotype of RBD patients which might shed light on the …
Page 1 of 4